Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand
Author Information
Author(s): Sathitruangsak Chirawadee, Pattarapuntakul Tanawat, Kaewdech Apichat, Thongkan Tortrakoon, Prisutkul Apinya, Thongwatchara Phatcharaporn, Sriplung Hutcha, Kongkamol Chanon, Kanokwiroon Kanyanatt, Obchoei Sumalee, Sripongpun Pimsiri
Primary Institution: Faculty of Medicine, Prince of Songkla University
Hypothesis
This study aimed to analyze the clinical characteristics and outcomes of CCA patients in Southern Thailand.
Conclusion
Most patients were diagnosed late, and the median overall survival was only 5–6 months, with better survival rates for unresectable CCA patients receiving systemic chemotherapy and palliative biliary drainage.
Supporting Evidence
- 59.4% of patients were diagnosed at TMN stage IV.
- Only 15.1% of the cohort were deemed resectable.
- The median overall survival for iCCA, pCCA, and dCCA patients were 27.3, 22.0, and 19.3 weeks, respectively.
- One-year survival rate differed significantly between resectable and unresectable patients (85.2% vs. 21.2%).
- TMN stage, palliative biliary drainage, and systemic chemotherapy were independent predictors for mortality in unresectable cholangiocarcinoma.
Takeaway
Cholangiocarcinoma patients in Southern Thailand often find out they have cancer too late, but those who get certain treatments can live longer.
Methodology
The study retrospectively reviewed 223 patients diagnosed with CCA between 2018 and 2021, analyzing clinicopathologic data and survival outcomes using Kaplan–Meier and Cox regression methods.
Potential Biases
Potential biases due to the retrospective nature of the study and missing data on certain variables.
Limitations
The study is retrospective, which may lead to missing information, and it lacks a control group to confirm the relationship between CCA and predisposing factors.
Participant Demographics
The mean age was 63.9 years, with 50.7% men; most patients were diagnosed at advanced stages.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI: 49–54 months
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website